• Marlin Wayne Causey, Daniel Nelson, Eric K Johnson, Justin Maykel, Brad Davis, David E Rivadeneira, Brad Champagne, and Scott R Steele.
• Department of Surgery, Madigan Army Medical System, Madigan Health System, 9040a Fitzsimmons Dr, Tacoma, WA 98431, USA.
• Am. J. Surg. 2014 Apr 1;207(4):520-6.

BackgroundThe Model for End-Stage Liver Disease Sodium Model (MELD-Na) is a validated scoring system that uses bilirubin, international normalized ratio, serum creatinine, and sodium to predict mortality in cirrhotic patients awaiting liver transplantation. The aim of this study was to identify the utility of MELD-Na to predict patient outcomes, with and without liver disease, after elective colon cancer surgery.MethodsA review of the American College of Surgeons National Surgical Quality Improvement Program database (2005 to 2010) was conducted to calculate risk-adjusted 30-day outcomes using regression modeling.ResultsA total of 10,842 patients (mean age, 68 years; 51% women) were included. MELD-Na scores were higher in men (10.2 vs 9.1, P < .001) and in open procedures (9.9 vs 9.1, P < .001). The overall complication and mortality rates were 26.3% and 3.3%, respectively. Incremental increases in MELD-Na score correlated with a 1.2% increase in mortality and a 1.1% increase in complications. On multivariate analysis, complications increased with MELD-Na score (odds ratio [OR], 1.05 per 1 point increase; 95% confidence interval [CI], 1.038 to 1.066). MELD-Na score was also associated with increased mortality (OR, 1.13; 95% CI, 1.1 to 1.16), along with ascites (OR, 5.7; 95% CI, 3.7 to 8.8) and corticosteroids (OR, 2.1; 95% CI, 1.3 to 3.3).ConclusionsElevated preoperative MELD-Na score is significantly associated with worse outcomes after elective resection for colon cancer.Published by Elsevier Inc.

37 keywords...

hide…